EUVIMEDOntdek EUVIMED
Open access

Ligand‐gated ion channels as potential biomarkers for ADT‐mediated cognitive decline in prostate cancer patients

Shiv Verma, Vaibhav Singh, VijayKrishna Nagampalli, Lee E Ponsky, Chiang-Shan R Li, Herta Chao, Sanjay Gupta iD

Molecular Carcinogenesis · 2024

DOI: 10.1002/mc.23708 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2024. Written by Shiv Verma and 6 co-authors. Institution: Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. Major MEDLINE topics: Cognitive Dysfunction, Prostatic Neoplasms. Cited 6 times so far (Crossref); 47 references. The full text is freely available in PubMed Central. Funded by: NIH HHS, U.S. Department of Defense, NCI NIH HHS.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Men with prostate cancer are at increased risk of developing cognitive decline by the use of second‐generation androgen signaling inhibitors. To date, reliable and sensitive biomarkers that could distinguish men at high risk of cognitive dysfunction under androgen deprivation therapy (ADT) have not been characterized. We used high‐throughput transcriptional profiling utilizing human prostate cancer cell culture models mimicking ADT, biomarker selection using minimal common oncology data elements‐cytoscape, and bioinformatic analyses employing Advaita® iPathwayGuide and DisGeNET for identification of disease‐related gene associations. Validation analysis of genes was performed on brain neuronal and glial cells by quantitative real‐time polymerase chain reaction assay. Our systematic analysis of androgen deprivation‐associated genes involved multiple biological processes, including neuroactive ligand–receptor interaction, axon guidance, cytokine–cytokine receptor interaction, and metabolic and cancer signaling pathways. Genes associated with neuroreceptor ligand interaction, including gamma‐aminobutyric acid (GABA) A and B receptors and nuclear core proteins, were identified as top upstream regulators. Functional enrichment and protein–protein interaction network analysis highlighted the role of ligand‐gated ion channels (LGICs) and their receptors in cognitive dysfunction. Gene–disease association assigned forgetfulness, intellectual disability, visuospatial deficit, bipolar disorder, and other neurocognitive impairment with upregulation of type‐1 angiotensin II receptor, brain‐derived neurotrophic factor, GABA type B receptor subunit 2 (GABBR2), GABRA3, GABRA5, GABRB1, glycine receptor beta, glutamate ionotropic receptor N‐methyl‐D‐aspartate receptor (NMDA) type subunit 1, glutamate ionotropic receptor NMDA type subunit 2D, 5‐hydroxytryptamine receptor 1D, interferon beta 1, and nuclear receptor subfamily 3 group C member 1 as top differentially expressed genes. Validation studies of brain glial cells, neurons, and patients on ADT demonstrated the association of these genes with cognitive decline. Our findings highlight LGICs as potential biomarkers for ADT‐mediated cognitive decline. Further validation of these biomarkers may lead to future practical clinical use.

Subjects

MeSH terms (MEDLINE)

Cognitive DysfunctionProstatic NeoplasmsHumansMaleBiomarkers, TumorAndrogen AntagonistsCell Line, TumorIon ChannelsGene Expression ProfilingGene Expression Regulation, NeoplasticProtein Interaction Maps

Author keywords

androgen deprivation therapybiomarkersbrain deficitscognitive declineprostate cancer

Substances

Biomarkers, TumorAndrogen AntagonistsIon Channels

Authors and institutions

  • Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Genomic Medicine Institute, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Psychiatry and of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Medicine, Yale Comprehensive Cancer Center, Yale University, New Haven, Connecticut, USA.

ORCID profiles: Sanjay Gupta

Funding

  • NIH HHS
  • U.S. Department of Defense
  • NCI NIH HHS
  • NCATS NIH HHS
  • Genomics Core Facility of the CWRU School of Medicine's Genetics and Genome Sciences Department
  • CSRD VA
  • National Cancer Institute

Cite

APA

Verma, S., Singh, V., Nagampalli, V., Ponsky, L. E., Li, C. R., Chao, H., & Gupta, S. (2024). Ligand‐gated ion channels as potential biomarkers for ADT‐mediated cognitive decline in prostate cancer patients. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23708

Vancouver

Verma S, Singh V, Nagampalli V, Ponsky LE, Li CR, Chao H, et al. Ligand‐gated ion channels as potential biomarkers for ADT‐mediated cognitive decline in prostate cancer patients. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23708

BibTeX
@article{Verma2024,
  author = {Verma, Shiv and Singh, Vaibhav and Nagampalli, VijayKrishna and Ponsky, Lee E and Li, Chiang-Shan R and Chao, Herta and Gupta, Sanjay},
  title = {Ligand‐gated ion channels as potential biomarkers for ADT‐mediated cognitive decline in prostate cancer patients},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  doi = {10.1002/mc.23708}
}
Start for free →